BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,058,816 | -11.6% | 478,506 | +6.7% | 0.04% | -14.0% |
| Q2 2023 | $20,432,157 | -86.8% | 448,467 | -88.3% | 0.04% | -88.3% |
| Q1 2023 | $154,889,555 | -56.9% | 3,818,776 | -45.7% | 0.37% | -62.4% |
| Q4 2022 | $359,080,691 | +0.3% | 7,035,280 | +5.9% | 0.98% | -15.0% |
| Q3 2022 | $357,847,000 | +1850.7% | 6,644,026 | +2226.2% | 1.15% | +1322.2% |
| Q2 2022 | $18,345,000 | -10.5% | 285,614 | +8.0% | 0.08% | 0.0% |
| Q1 2022 | $20,499,000 | -5.1% | 264,361 | +6.3% | 0.08% | -5.8% |
| Q4 2021 | $21,603,000 | +25.1% | 248,687 | +15.9% | 0.09% | +1.2% |
| Q3 2021 | $17,265,000 | +11.4% | 214,661 | +11.5% | 0.08% | +1.2% |
| Q2 2021 | $15,504,000 | +9.7% | 192,598 | +15.0% | 0.08% | -9.7% |
| Q1 2021 | $14,130,000 | +17.5% | 167,538 | +11.8% | 0.09% | 0.0% |
| Q4 2020 | $12,023,000 | +4.5% | 149,840 | +4.7% | 0.09% | -12.3% |
| Q3 2020 | $11,508,000 | +10.2% | 143,097 | +17.9% | 0.11% | -10.9% |
| Q2 2020 | $10,446,000 | +26.3% | 121,329 | +19.1% | 0.12% | -7.0% |
| Q1 2020 | $8,269,000 | -4.7% | 101,848 | +0.4% | 0.13% | +13.3% |
| Q4 2019 | $8,676,000 | +10.3% | 101,476 | +12.9% | 0.11% | -11.7% |
| Q3 2019 | $7,865,000 | +12.0% | 89,917 | +4.8% | 0.13% | +6.7% |
| Q2 2019 | $7,024,000 | +21.1% | 85,759 | +20.3% | 0.12% | +0.8% |
| Q1 2019 | $5,798,000 | +30.9% | 71,304 | +3.8% | 0.12% | +6.2% |
| Q4 2018 | $4,430,000 | -21.0% | 68,706 | -5.6% | 0.11% | -2.6% |
| Q3 2018 | $5,609,000 | +1.9% | 72,758 | -2.4% | 0.12% | -5.7% |
| Q2 2018 | $5,504,000 | +16.3% | 74,546 | +2.5% | 0.12% | +10.9% |
| Q1 2018 | $4,733,000 | -11.2% | 72,763 | -6.8% | 0.11% | -5.2% |
| Q4 2017 | $5,329,000 | +10.4% | 78,082 | +1.5% | 0.12% | +1.8% |
| Q3 2017 | $4,827,000 | +7.5% | 76,919 | +3.7% | 0.11% | +3.6% |
| Q2 2017 | $4,490,000 | +4.1% | 74,167 | -10.8% | 0.11% | +12.2% |
| Q1 2017 | $4,313,000 | +20.4% | 83,160 | +3.1% | 0.10% | +12.6% |
| Q4 2016 | $3,583,000 | -0.7% | 80,635 | +6.3% | 0.09% | -3.3% |
| Q3 2016 | $3,609,000 | +7.7% | 75,824 | +2.4% | 0.09% | +3.4% |
| Q2 2016 | $3,350,000 | +2.6% | 74,079 | -6.8% | 0.09% | -1.1% |
| Q1 2016 | $3,264,000 | +18.1% | 79,461 | +9.7% | 0.09% | +10.0% |
| Q4 2015 | $2,763,000 | +23.5% | 72,412 | +6.3% | 0.08% | +12.7% |
| Q3 2015 | $2,238,000 | -53.1% | 68,142 | -0.1% | 0.07% | -51.4% |
| Q2 2015 | $4,770,000 | -4.3% | 68,213 | -6.2% | 0.15% | -0.7% |
| Q1 2015 | $4,982,000 | -11.6% | 72,723 | -5.4% | 0.15% | -15.5% |
| Q4 2014 | $5,637,000 | -10.1% | 76,886 | -12.0% | 0.17% | -7.4% |
| Q3 2014 | $6,271,000 | -17.9% | 87,372 | -17.3% | 0.19% | -4.1% |
| Q2 2014 | $7,642,000 | -2.1% | 105,705 | -0.4% | 0.20% | -5.8% |
| Q1 2014 | $7,807,000 | +12.3% | 106,098 | +5.8% | 0.21% | +4.5% |
| Q4 2013 | $6,951,000 | -15.3% | 100,309 | -19.7% | 0.20% | -7.0% |
| Q3 2013 | $8,207,000 | -0.0% | 124,940 | +5.4% | 0.21% | -8.5% |
| Q2 2013 | $8,208,000 | – | 118,500 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |